Related Experiment Video
Updated: Jan 3, 2026

Polygraphic Recording Procedure for Measuring Sleep in Mice
Published on: January 25, 2016
Hypnotics with novel modes of action
Daniel Hoyer1,2,3, Andrew Allen1, Laura H Jacobson1,2
1Department of Pharmacology & Therapeutics, School of Biomedical Sciences, Faculty of Medicine, Dentistry and Health Sciences, The University of Melbourne, Parkville, Victoria, Australia.
New hypnotics targeting the orexin system offer a promising alternative for insomnia treatment. These drugs may provide improved safety profiles, with fewer side effects like memory impairment and dependence compared to traditional options.
Area of Science:
- Neuroscience
- Pharmacology
- Sleep Medicine
Background:
- Rising prevalence of insomnia and sleep disturbances.
- Traditional insomnia treatments include GABAergic drugs (benzodiazepines, Z drugs) and cognitive behavioral therapy.
- Limitations of classical hypnotics include drug-drug interactions, memory impairment, and dependence potential.
Purpose of the Study:
- To review new hypnotic medications.
- To discuss the orexin/hypocretin system as a novel therapeutic target for insomnia.
- To compare the potential side effect profiles of new orexin-targeting hypnotics with classical agents.
Main Methods:
- Literature review of recent pharmacological developments in insomnia treatment.
- Analysis of the mechanism of action of orexin receptor antagonists.
- Comparative assessment of safety and efficacy data for novel hypnotics versus traditional therapies.
Main Results:
- Suvorexant and similar agents target the orexin/hypocretin system.
- Orexin-targeting drugs are associated with a potentially lower risk of drug-drug interactions (e.g., with alcohol).
- These newer medications may offer reduced memory impairment and dependence potential.
Conclusions:
- Orexin receptor antagonists represent a significant advancement in insomnia pharmacotherapy.
- Newer hypnotics offer a potentially improved safety and tolerability profile.
- Targeting the orexin system provides a novel therapeutic avenue for managing sleep disorders.
More Related Videos
14:52Recording Brain Electromagnetic Activity During the Administration of the Gaseous Anesthetic Agents Xenon and Nitrous Oxide in Healthy Volunteers
Published on: January 13, 2018
08:49Assessing Changes in Volatile General Anesthetic Sensitivity of Mice after Local or Systemic Pharmacological Intervention
Published on: October 16, 2013
Related Concept Videos
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Sedatives and Hypnotics: Overview
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedatives and Hypnotics Drugs: Benzodiazepines
Benzodiazepines work by enhancing the effects of the inhibitory neurotransmitter GABA. They bind to the GABAA receptor, increasing its affinity for GABA, which opens chloride...
Management of Insomnia
Sedatives and Hypnotics Drugs: Barbiturates
CNS Depressants: Barbiturates and Benzodiazepines